315
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Two sesquiterpene pyridine alkaloids and a triterpenoid saponin from the root barks of Tripterygium hypoglaucum

, , , , &
Pages 973-980 | Received 03 Jul 2012, Accepted 07 Sep 2012, Published online: 10 Oct 2012
 

Abstract

Two new sesquiterpene pyridine alkaloids hypoglaunines E (1) and F (2) and a new triterpenoid saponin hypoglaside A (3), together with a known diterpenoid glucoside 11-O-β-d-glucopyranosyl neotriptophenolide (4) and two known triterpenoids 23-nor-oxopristimerol (5) and 2,3-dihydroxy-6-oxo-D:A-froedo-24 nor-1,3,5(10),7-oleanatetraen-29-oic acid (6), have been isolated from the root barks of Tripterygium hypoglaucum. Their structures were elucidated by NMR spectroscopy and MS analysis. Compounds 13 were screened for their cytotoxic activities against five cancer cell lines, but all of them were inactive.

Acknowledgements

We are grateful to the Department of Instrumental Analysis at the Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College for all spectroscopic analyses. We also thank the Department of Pharmacology at the Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College for the bioactivity tests. This work was financially supported by the National Key Technology R&D Program of China (Nos 2009BA173B03 and 2011BAI01B05) and the Science and Technology Major Project of Fujian Province (No. 2009YZ0001-1-6).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.